Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

NCT0262562375 sitesClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)